Bristol-Myers says a key trial for its lung cancer drug succeeds

Bristol-Myers Squibb also reported a loss due to a charge it took related to recent U.S. tax law changes.
Source: CNBC

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>